Page 24 - Exact Sciences Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The power and influence of ARK Innovation ETF and Cathie Wood's range of active ETFs – a two minute explainer The success of the funds means they can move markets and are inspiring launches of other active ETFs ARK founder Cathie Wood ARK Innovation ETF (NYSEARCA:ARKK) and chief stockpicker Cathie Wood have become such investor favourites over the past year they have the power to move markets. Although the ETFs are not tradeable in the UK, the strong record from the asset manager’s range of funds, and her regular appearances on financial TV channels, means Wood and her multi-b...

Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope Talented team and industry-leading lab will help strengthen the company's sequencing and pipeline capabilities, while broadening its therapy selection and treatment guidance offerings News provided by Share this article (PRNewsfoto/EXACT SCIENCES CORP) (PRNewsfoto/EXACT SCIENCES CORP) MADISON, Wis., April 14, 2021 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its previously announced acquisition of Ashion A...

Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following virtual conferences and invited investors to participate by webcast.

Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hope's Genomics Institute, TGen Provides Access to Industry-Leading Sequencing Lab and Plans for 10-Year Partnership with National Cancer Research Leaders News provided by Share this article (PRNewsfoto/EXACT SCIENCES CORP) (PRNewsfoto/EXACT SCIENCES CORP) MADISON, Wis., Feb. 16, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has entered into an agreement to acquire Ashion Analytics, LLC (Ashion) from The Translational Genomics Research Institute (TGen), an affiliate of...

Exact Sciences Announces Fourth Quarter 2020 Results News provided by Share this article Share this article MADISON, Wis., Feb. 16, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $466.3 million for the fourth quarter ended Dec. 31, 2020 and $1,491.4 million for the full year ended Dec. 31, 2020. "Exact Sciences finished another transformative year by delivering strong fourth quarter results against a challenging backdrop because of the pandemic," said Kevin Conroy, chairman and CEO of Exact Sciences. "We are a leader in cancer...